🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, double-blind, placebo-controlled, crossover, dose escalation ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-09
Trial ID
NCT02349425
Treatments Being Tested
The purpose of this study is to assess the efficacy of gefapixant (AF-219/M...
Status
Terminated
Location
Afferent Investigative Site
Start Date
2012-04-13
Trial ID
NCT01569438
Treatments Being Tested
This trial aims to evaluate the plasma pharmacokinetics of gefapixant (MK-7...
Status
Completed
Location
Clinical Pharmacology of Miami ( Site 0001)
Start Date
2017-04-14
Trial ID
NCT03108924
Treatments Being Tested
This is a randomized, double-blind, double-dummy, placebo-controlled, three...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-16
Trial ID
NCT01993329
This study assesses the tolerability of a single dose of gefapixant (AF-219...
Status
Completed
Location
American Health Research
Start Date
2015-07-20
Trial ID
NCT02477709
Treatments Being Tested
The primary objective of this study was to assess the effect of a single do...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-28
Trial ID
NCT02476890
Treatments Being Tested
This was an 8-week randomized, parallel, double-blind, placebo-controlled s...
Status
Completed
Location
Afferent Investigative Site
Start Date
2015-12-17
Trial ID
NCT02612623
Treatments Being Tested
The purpose of this study is to compare the multiple dose pharmacokinetics ...
Status
Completed
Location
Celerion
Start Date
2015-07-07
Trial ID
NCT02492776
Treatments Being Tested
This study is designed to evaluate the efficacy of three dose regimens of g...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-15
Trial ID
NCT02612610
Treatments Being Tested
The primary objective of this double-blind crossover study is to assess the...
Status
Completed
Location
The Medicines Evaluation Unit
Start Date
2015-04-29
Trial ID
NCT02397460
Treatments Being Tested